Financial conflicts of interest in physicians' relationships with the pharmaceutical industry--self-regulation in the shadow of federal prosecution.

Harvard School of Public Health, Boston, USA.
New England Journal of Medicine (Impact Factor: 54.42). 11/2004; 351(18):1891-900. DOI: 10.1056/NEJMlim042229
Source: PubMed
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objectives To describe the current extent and type of pharmaceutical marketing in nursing homes (NHs) in one state and to provide preliminary evidence for the potential influence of pharmaceutical marketing on the use of atypical antipsychotics in NHs.DesignNested mixed-methods, cross-sectional study of NHs in a cluster randomized trial.SettingForty-one NHs in Connecticut.ParticipantsNH administrators, directors of nursing, and medical directors (n = 93, response rate 75.6%).MeasurementsQuantitative data, including prescription drug dispensing data (September 2009–August 2010) linked with Nursing Home Compare data (April 2011), were used to determine facility-level prevalence of atypical antipsychotic use, facility-level characteristics, NH staffing, and NH quality. Qualitative data, including semistructured interviews and surveys of NH leaders conducted in the first quarter of 2011, were used to determine encounters with pharmaceutical marketing.ResultsLeadership at 46.3% of NHs (n = 19) reported pharmaceutical marketing encounters, consisting of educational training, written and Internet-based materials, and sponsored training. No association was detected between level of atypical antipsychotic prescribing and reports of any pharmaceutical marketing by at least one NH leader.ConclusionNH leaders frequently encounter pharmaceutical marketing through a variety of ways, although the impact on atypical antipsychotic prescribing is unclear.
    Journal of the American Geriatrics Society 02/2015; 63(2). DOI:10.1111/jgs.13180 · 4.22 Impact Factor
  • Journal of Medical Marketing 11/2012; 12(4):240-246. DOI:10.1177/1745790412455942
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Objective: Evaluating the quality of promotional information that given by medical representatives (MRs) to physicians in Iraq. Methods: A survey in questionnaire format for 22 specialist physician was done in Baghdad governorate during March – October 2013. The questionnaire involve questions about the age, gender, occupation of the physician besides 4 different questions regarding reliability, accuracy, and benefit from promotional information to the Iraqi physician. Results: Medical representatives provide physicians with good information about drug indication and weak information about drug contraindications and side effects. On the other hand, academic physicians have a significantly more negative opinion than physicians who work in hospitals regarding the reliability of promotional information. Furthermore only hospital physicians found that MRs Information are useful for them. There is a non significant difference among physicians who directly trust the information from drug companies and MRs from those who don't trust unless check the data by themselves using suitable reference books or journals. Conclusion: MRs provide Iraqi physicians with biased information, yet non academic physicians found that information is beneficial for their clinical practice.
    International Journal of Pharmacy and Pharmaceutical Sciences 01/2014; 6(1). · 1.59 Impact Factor


1 Download
Available from